Replies to post #176642 on Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

A glowing example of a complete lack of understanding. The presentation includes unpublished and not previously reported findings and will also include parallel/confirmatory data from Phase 1. It should also cover additional detail for the ongoing Phase 2 OC and what they will be looking to define better and further confirm.

Another presentation with mice data.

What is use of mice data - been similar data for 4 years now.

Yawn

[TheHound]

Speaking of cancer and companies trying to save lives,...

God bless all the young ones battling cancer. Here's a cool 2106 Christmas story from Owings Mills, MD - "Young Boy With Cancer Transformed Into Super Hero. http://baltimore.cbslocal.com/2016/12/17/young-boy-with-cancer-transformed-into-super-hero/

Cellceutix's Kevetrin drug received Rare Pediatric Disease Designation from the FDA for Orphan Drug treatment of retinoblastoma, a rare type of eye cancer that originates in the retina. The big benefit of the designation is the opportunity to apply for a Rare Pediatric Disease Review Voucher, which can be used for Priority Review (six months) of a future NDA or can be sold to a third party. The vouchers are quite valuable. In 2014, AbbVie bought one from United Therapeutics for $350M in cash. Yet another opportunity for Cellceutix to save young ones battling cancer.

[georgejjl]

Another post complaining about FACTS.

What use are these FUD posts? Are they just to instill FEAR, UNCERTAINTY and DOUBT in honest investors minds?

GOD bless,

George